CD8A and neoplasm: A significant increase in the tumor infiltrating CD8 T cells in the CA-170 in combination with cyclophosphamide group led to a favorable tumor suppressive CD8 T cell: FoxP3 ratio, thus accounting for the enhanced efficacy in this group (Supplementary Fig. 2).